ArticleInsights into imaging2024

CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn's disease.

Tian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.